Fig. 1: Consolidated-standards-of-reporting trials diagram showing screening and treatment allocation.

Dashed lines indicate participants who withdrew from dosing but stayed in the trial and were included in the final analysis.

Dashed lines indicate participants who withdrew from dosing but stayed in the trial and were included in the final analysis.